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Epidermal cells (EC) are a rich source of cytokines that can 
regulate the function of cells in skin and in other tissues. To 
organize the array of data pertaining to cytokine expression 
by EC subpopulations, we have tabulated such data according 
to cell source, state of cell activation, and type of assay em-
ployed. This information forms a background for our own 
T he epidermis contains cells of different lineages that are capable of exerting autocrine, paracrine, and en-docrine influences. The principal mechanism by which epidermal cells (EC) achieve these effects is through the elaboration of soluble protein factors 
termed cytokines. In fact, keratinocytes (KC), which comprise the 
vast majority ofEC in both human and mouse skin, are now recog-
nized as a rich source of numerous cytokines, many of which can 
regulate immunologic events [1- 3]. With respect to cytokine ex-
pression by other EC, considerably less is known because of difficul-
ties in procuring sufficient numbers of highly purified EC subpopu-
lations for conventional cytokine assays, such as functional 
bioassays, enzyme-linked immunosorbent assays, or Northern and 
Western blotting. Recently, use of the highly sensitive technique of 
reverse-transcriptases - polymerase chain reaction (RT -PCR) has 
obviated some of the limitations imposed by the technical difficul-
ties cited above. 
A long-term goal of our laboratory has been to elucidate, at molec-
ular levels, mechanisms responsible for the initiation and regulation 
of immunologic events in epidermis. This has required examination 
of cytokines expressed by individual EC subpopulations, with initial 
studies focused on LC and dendritic epidermal T cells (DETC) in 
mice using RT-PCR. We compared cytokine mRNA from epider-
mal sheets that were separated from dermis using ammonium thio-
cyanate, undepleted EC disaggregated using trypsin, and EC de-
pleted of LC by lysis using anti-Ia monoclonal antibody and 
complement (Table I) . PCR signals of mRNA from the first two 
sources were virtually indistinguishable whereas those from LC-de-
pleted EC showed a marked decrease in interleukin 1P (IL-1P) and 
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Abbreviations: 
DETC: dendritic epidermal T cells 
EC: epidermal cells 
FACS: fluorescein-activated cell sorter 
KC: keratinocytes 
LC: Langerhans cells 
MC: melanocytes 
MIP-1a: macrophage inflammatory protein-1a 
RT -PCR: reverse-transcriptase - polymerase chain reaction 
studies, in which reverse transcriptase - polymerase chain re-
action (RT-PCR) was used to show that Langerhans cells 
(LC) are the principal source of mRNA for interleukin 1ft and 
macrophage inflammatory protein-1a (MIP-1a) among un-
stimulated mouse EC.l Invest Dermatoi99:42S-45S, 1992 
macrophage inflammatory protein-1a (MIP-1a). In subsequent ex-
periments, fluorescein-activated cell sorter (FACS) -sorted Ia- and 
Ia+ EC populations indicated Ia+ EC (LC) to be the principal source 
of IL-1P and MIP-la among EC (data not shown). 
During the course of these studies, it became apparent that three 
e~perimental vari.ables, cell source, state of activatio~, and the spe-
Cific assay, have lllfluenced the results and conclUSIOns of earlier 
studies [4 -45] (Tables II and III). In particular, the state of cell 
activation (none, cytokines, mitogens, or ultraviolet) and the assay 
that was chosen (biologic activities, biochemical properties, antige-
nicity, or mRNA) have had important effects on the outcome of 
reported studies. These must be taken into account whenever com-
parisons are made. 
Th is study was supported itJ part by grants from the NIH (AR 40042 atJd AR 
35068), Kao Corporation, atJd L.B. Simotl, Itlc. 
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Table I. Cytokine mRNA Expression by Unstimulated Mouse Epidermal Cellsa 
IL-la IL-lP IL-2 IL-4 IL-5 IL-6 IL-7 IFNy GM-CSF MIP-la TN Fa TNFP 
Epidermal sheets ++ ++ ± + ++ ++ ± ++ ++ ++ + 
Epidermal cells (Ee) ++ ++ ± + ++ ++ ± ++ ++ ++ + 
Ee depleted of LC ++ ± ± + ++ ++ ± ++ ++ + 
• mRNA expression in the different preparations can be compared for each cytokine, but not among cytokines. Data shown represent PCR signals: strong (++), fair (+), faint (±), 
and none (-). 
Table II. Cytokines Expressed by Human Epidermal Cell Populations 
Cell Source" Constitutive 
(purification) Cytokine Expression Stimulant Assayb Reference 
Keratinocytes (Ke) 
ETAF + Bioassay, biochemical [4) cEC, SCC 
cKC, A431 ETAF (IL-la > IL-lfJ) + Bioassay, Ab block, Sl nu- [5] 
c1ease protection 
cKC IL-la,IL-lp + PMA, UYB Bioassay, S 1 nuclease protec-
tion 
[6] 
cKC IL-la + IL-la, TGFa ELISA, dot [7] 
cKC pro-IL-lP + Bioassay, Western, ELISA [8] 
cEC, A431, SCC IL-3-like factor + PMA,LPS Bioassay, biochemical [9] 
cEC, SCC NK augumenting factor + Bioassay, biochemical [10] 
cKC, A431, KB IL-6 + IL-la, IL-lP, PMA Bioassay, biochemical, Ab [11] 
block, Western, Northern 
cKC, RHEK-l IL-6 + IL-la, IL-4, TNFa, PMS, LPS Bioassay, Western, immuno-
precipitation, Northern, Sl 
[12] 
nuclease protection 
cKC IL-8 IL-la, TNFa Bioassay, Northern [13] 
cKC IL-8 TNFa, TNFa + IFNy, TPA Northern [14] 
cKC MCAF' + IFNy, IFNy, + TNFa Bioassay, biochemical, Ab [14,15] 
block, immunoprecipita-
tion, Northern 
eKe IP- I0d IFNy Imu1Unoprecipitation, [16] 
Northern 
cKC, A431 GM-CSF + Bioassay, biochemical, Ab [17] 
block 
cEC, COLO-16 GM-CSF, G-CSF, IL-3-like + Bioassay, biochemical [18] 
factor 
cKC M-CSF + LPS Bioassay, Western, Northern [19] 
cKC, A431, KB TNFa UYB, LPS Bioassay, Western, ELISA, [20] 
Northern 
cKC, Skin section IFNa + Bioassay, immunofluores- [21] 
cence, Western 
cEC, COLO-16 Hepatocyte stimulating factor + Bioassay, biochemical, [22] 
III (LIF)' Northern 
cKC Lymphocyte differentiating + Bioassay, biochemical [23] 
factor 
£BC, Skin section Thymopoietin-Iike factor + Immunofluorescence [24] 
Langerhans cel ls (Le) 
IL-1 + Bioassay, Ab block (25) cLC (Panning) 
cLC (Panning) IL-1P PMA + LPS Dot [26] 
cLC (Panning) TNFa PMA+LPS Bioassay, Ab block, dot [27] 
Melanocytes (Me) 
IL-1a,IL-lp + Melanoma Bioassay, biochemical , Ab [28] 
block, Northern 
Melanoma IL-6 IL-1a ELISA, Northern (29) 
cMC IL-8, MCAF IL-la, TNFa Bioassay, RIA, Northern [30] 
Melanoma G-CSF Bioassay, biochemical, [31] 
Northern 
Melanoma TNFa + Immunohistochemistry, [32] 
Northern 
• Cell sources include freshly isolated (f) and cultured (c) cells, and transfonned cell lines. 
I Assays include measurements of biologic activity .(bioassay), biochemical ch~cterization, detennination of antigenicity (antibody blocking, Western blot, ELISA, immunopre-
cipitation, RIA, immunofluorescence and lIlununohlstochetnlstry, and exanunatlon of mRNA (S1nuclease protection assay, Northern and Dot blot, and RT-PCR). 
, Monocyte chemotaxis and activating factor. 
J Interferon-induced protein 10. 
, Leukemia-inhibitory factor. 
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Table ill. Cytokines Expressed by Mouse Epidermal Cell Populations 
Cell Source Constitutive 
(purification) Cytokine Expression 
Keratinocytes (KC) 
cEC (LC-depletion) ETAF + 
cEC, Pam212 IL-1a + 
cEC, Pam212 IL-3 + 
Pam212 IL-3, GM-GSF + 
Pam212 IL-7 + 
Pam212 KTGF{GM-CSF) + 
Pam212 M-CSF + 
cEC, Pam212 DTH suppressive factor 
cEC, Pam212 Contra-IL-1 
Langerhans cells (LC) 
fLC (FACS) IL-1fi, MIP-1a + 
fEC (LC-depletion) IL-1fi + 
cLC (Density gradient) IL-6 + 
Dendritic epidermal T 
cells (DETC) 
DETC clone IL-2 
DETC clone IL-4 + 
DETC clone GM-CSF + 
• Muramyl dipeptide. 
I Extracellular matrix proteins. 
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